Statement Of Cash Flows [Abstract]

BioGaia - Filing #5861821

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations	373 217 SEK	—	425 965 SEK	—	—
Interest paid, classified as operating activities	1 446 SEK	—	7 89 SEK	—	—
Interest received, classified as operating activities	39 363 SEK	—	41 250 SEK	—	—
Income taxes paid (refund), classified as operating activities	111 514 SEK	—	80 294 SEK	—	—
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities	80,000 SEK	—	- SEK	—	—
Purchase of property, plant and equipment, classified as investing activities	13 756 SEK	—	48 5 6 8 SEK	—	—
Purchase of intangible assets, classified as investing activities	3 97 SEK	—	146,000 SEK	—	—
Purchase of other long-term assets, classified as investing activities	- SEK	—	2 221 SEK	—	—
Cash flows from (used in) investing activities	14 073 SEK	—	50 935 SEK	—	—
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares	20 815 SEK	—	- SEK	—	—
Payments of other equity instruments	- SEK	—	417,000 SEK	—	—
Payments of lease liabilities, classified as financing activities	9 355 SEK	—	10 755 SEK	—	—
Dividends paid, classified as financing activities	696 778 SEK	—	2 92 8 49 SEK	—	—
Other inflows (outflows) of cash, classified as financing activities	4 400 SEK	—	4 400 SEK	—	—
Cash flows from (used in) financing activities	68 9 71 8 SEK	—	3 08 42 1 SEK	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	330 574 SEK	—	66 609 SEK	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	10 366 SEK	—	1 0 78 3 SEK	—	—
Cash and cash equivalents	—	1 223 984 SEK	—	1 544 192 SEK	1 488 366 SEK